27 September 2017
Pennsylvania
Reporter: Barney Dixon

Amgen sues Mylan over Neulasta


Amgen has sued Mylan at the US District Court for the Western District of Pennsylvania over patents relating to its Neulasta (pegfilgrastim) chemotherapy support drug.

In February, the US Food and Drug Administration (FDA) accepted Mylan’s abbreviated Biologics License Application (aBLA) for the Neulasta biosimilar for review, but the FDA is yet to approve the application.

In its complaint, Amgen explained that approval of the biosimilar and Mylan’s potential importation and sale of its product would be “infringing”.

Both Amgen and Mylan started exchanging information in March this year under the so-called ‘patent dance’ procedure of the Biologics Price Competition and Innovation Act (BPCIA).

However, Amgen suggested that Mylan failed to provide certain information and “materially prejudiced and impeded Amgen’s ability to review the Mylan aBLA”.

Amgen alleged that Mylan “failed to provide other information that describes the process or processes used to manufacture the biological product that is the subject of’ the Mylan aBLA”.

In June, Amgen took to the US Supreme Court to challenge a US Court of Appeals for the Federal Circuit decision that said the patent dance procedures were completely optional and that a biosimilar applicant can decide to withhold a copy of its biosimilar application.

Amgen said the patent dance was part of the BPCIA’s trade-off and balanced the rights of reference products against those of biosimilar applicants.

The case was sent back to the court of appeals to for a further ruling.

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Cabinet Plasseraud promotes four to partner
21 February 2018 | Paris | Reporter: Barney Dixon
Cabinet Plasseraud has appointed for intellectual property attorneys to partner
NPE litigation in Europe sees continued growth
20 February 2018 | Brussels | Reporter: Barney Dixon
NPE litigation and enforcement in Europe has increased by an average almost 20 percent year-on-year since 2007, according to a new report from Darts-IP
BakerHostetler hires IP partner
19 February 2018 | Los Angeles | Reporter: Barney Dixon
BakerHostetler has hired Troy Schmelzer as partner in its intellectual property group
Sheppard, Mullin, Richter & Hampton promotes four to partner
16 February 2018 | California | Reporter: Barney Dixon
Sheppard, Mullin, Richter & Hampton has promoted four intellectual property attorneys to partner across its Shanghai, San Diego and San Francisco offices
Latest EPO employment proposals under fire
15 February 2018 | Munich | Reporter: Barney Dixon
The latest version of a proposal to scrap permanent employment contracts at EPO for the “modernisation” of its employment framework has come under fire
Munck Wilson Mandala hires IP associate
14 February 2018 | Dallas | Reporter: Barney Dixon
Munck Wilson Mandala has hired Chad Ray as senior associate in its Dallas, Texas office
Anaqua partners with Ceva Santé Animale
13 February 2018 | Boston | Reporter: Barney Dixon
Animal healthcare company Ceva Santé Animale has chosen Anaqua to manage its intellectual property portfolio